Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-01-26 to 2023-01-27
Current total value of award: $361.14
Description: 4559734700!MAXZIDE 75 MG-50 MG TABLET 100S